NASONEX (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the NASONEX drug offered from Merck Sharp & Dohme Corp.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: Mometasone furoate monohydrate
SUBSTANCE NAME: MOMETASONE FUROATE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-10-01
END MARKETING DATE: 0000-00-00


NASONEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNASONEX from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/1)
START MARKETING DATE: 1997-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0085-1288_64c52e50-dc68-43cd-b73d-bb6542997f2a
PRODUCT NDC: 0085-1288
APPLICATION NUMBER: NDA020762

Other MOMETASONE FUROATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.NASONEX
REMEDYREPACK INC.NASONEX
Sandoz Inc.Mometasone Furoate Monohydrate